A5076348879- Primary Care and Health Outcomes
- Chronic Disease Management Strategies
- Lipoproteins and Cardiovascular Health
- Gout, Hyperuricemia, Uric Acid
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Pharmaceutical Practices and Patient Outcomes
- Cardiovascular Issues in Pregnancy
- Diabetes Management and Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Clinical practice guidelines implementation
- Diabetes Management and Education
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Fatty Acid Research and Health
- Health Promotion and Cardiovascular Prevention
- Cardiac Valve Diseases and Treatments
- Heart Failure Treatment and Management
- Case Reports on Hematomas
- Artificial Intelligence in Healthcare
- Diabetes Treatment and Management
- Natural Products and Biological Research
- Nausea and vomiting management
- Inflammasome and immune disorders
- Renin-Angiotensin System Studies
University of Dundee
2009-2024
Montrose Center
1997-2018
Edinburgh Royal Infirmary
2003
University of Aberdeen
1996
Allopurinol is a urate-lowering therapy used to treat patients with gout. Previous studies have shown that allopurinol has positive effects on several cardiovascular parameters. The ALL-HEART study aimed determine whether improves major outcomes in ischaemic heart disease.ALL-HEART was multicentre, prospective, randomised, open-label, blinded-endpoint trial done 18 regional centres England and Scotland, recruited from 424 primary care practices. Eligible were aged 60 years or older, disease...
Introduction Ischaemic heart disease (IHD) is one of the most common causes death in UK and treatment patients with IHD costs National Health System (NHS) billions pounds each year. Allopurinol a xanthine oxidase inhibitor used to prevent gout that also has several positive effects on cardiovascular system. The ALL-HEART study aims determine whether allopurinol improves outcomes IHD. Methods analysis multicentre, controlled, prospective, randomised, open-label blinded end point (PROBE) trial...
Adherence to evidence-based treatments and its consequences after acute myocardial infarction (MI) are poorly defined. We examined the extent which clopidogrel treatment initiated in hospital is continued primary care; factors predictive of discontinuation hazard death or recurrent MI. linked Myocardial Ischaemia National Audit Project registry General Practice Research Database examine adherence care among patients discharged from MI (2003–2009). Hospital Episode Statistics national...
Abstract Background Allopurinol is a xanthine oxidase inhibitor that lowers serum uric acid and used to prevent acute gout flares in patients with gout. Observational small interventional studies have suggested beneficial cardiovascular effects of allopurinol. Objective To determine whether allopurinol improves major outcomes ischaemic heart disease. Design Prospective, randomised, open-label, blinded endpoint multicentre clinical trial. Setting Four hundred twenty-four UK primary care...
We assessed patients after their return home following gynaecological surgery, using a daily electronic diary. Thirty-two females aged 27-77 years took part. After hospital stay of 1-6 days (mean 2.3), they were given pen-based diary and asked to record symptoms other data over one month. They also completed questionnaire at the end study. Substantial effects on quality duration sleep, pain during both night day, interference with activities, energy, ability concentrate recorded, mostly...
The COVID‐19 pandemic has meant that the use of a technology‐based remote approach to health care is necessary in order keep staff and patients safe. Here, Dr Alan Begg evaluates TECS now whether or not they have potential enhance delivery effective for diabetes patients.
(2013). Insulin therapy: a pocket guide. European Diabetes Nursing: Vol. 10, No. 2, pp. 51-51.
The COVID-19 pandemic over the past two years has necessitated a significant change in our traditional approach to diabetes research, structured care of people with and efforts prevent diabetes. Some research studies have had be paused because difficulty arranging direct contact those recruited specific studies. Research related infection has, however, been important determining both risk treatment strategies. Patients become used routine reviews being postponed or cancelled aspects...
Abstract In England both diabetes and coronary heart disease are now covered for a 10‐year period by national service frameworks. National directors have been appointed to provide high profile leadership with responsibility achieving overall success. Significant progress date is claimed the improvement in prevention, diagnosis treatment of patients disease. Systematic care increases workload, requires more staff additional financial resources. Implementation frameworks dependent on funding...
Allopurinol is licensed in the United Kingdom for prophylaxis of gout as well uric acid and calcium oxalate renal stones. It can also be prescribed hyperuricaemia associated with cancer chemotherapy. effectively lowers serum levels reduces risk recurrent symptoms. commenced after an acute attack has fully subsided to avoid precipitating a flare The recommended starting dose 100mg reduce adverse reactions subsequently increased if urate lowering response unsatisfactory.1 drug tolerated...
It should be standard practice for general practitioners (GPs) when reviewing a hospital admission in patient with diabetes to take the opportunity reflect on whether any aspect of that patient's diabetic care could have been improved prevent admission. The Primary Care Diabetes Society (PCDS) has recently launched report from group clinical experts ‘Keeping People out Hospital’.1 which met Westminster two occasions last summer included three members All-Party Group Diabetes, whom were...
Abstract Alan Begg investigates health disparities between different regions of the UK, looking in particular at north–south divide men's health. Copyright © 2012 John Wiley & Sons